ReWalk Robotics Ltd (LFWD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ReWalk Robotics Ltd (LFWD) has a cash flow conversion efficiency ratio of -0.584x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.67 Million) by net assets ($6.29 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See LFWD defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
ReWalk Robotics Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how ReWalk Robotics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
ReWalk Robotics Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ReWalk Robotics Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Burcon NutraScience Corporation
TO:BU
|
0.640x |
|
Maisons du Monde SAS
PA:MDM
|
-0.014x |
|
Sensei Biotherapeutics Inc
NASDAQ:SNSE
|
-0.056x |
|
Catena Media plc
ST:CTM
|
0.055x |
|
Teck Guan Perdana Bhd
KLSE:7439
|
0.172x |
|
Oxford Instruments PLC
LSE:OXIG
|
0.155x |
|
Comfort Gloves Bhd
KLSE:2127
|
0.003x |
|
LQwD FinTech Corp
V:LQWD
|
-0.022x |
Annual Cash Flow Conversion Efficiency for ReWalk Robotics Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of ReWalk Robotics Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of ReWalk Robotics Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $8.41 Million | $-16.83 Million | -2.001x | -73.68% |
| 2024-12-31 | $18.85 Million | $-21.72 Million | -1.152x | -159.30% |
| 2023-12-31 | $46.51 Million | $-20.67 Million | -0.444x | -69.30% |
| 2022-12-31 | $68.17 Million | $-17.89 Million | -0.262x | -104.55% |
| 2021-12-31 | $89.38 Million | $-11.47 Million | -0.128x | +77.81% |
| 2020-12-31 | $21.77 Million | $-12.59 Million | -0.578x | +57.93% |
| 2019-12-31 | $10.78 Million | $-14.81 Million | -1.374x | +81.91% |
| 2018-12-31 | $1.95 Million | $-14.77 Million | -7.596x | -25.16% |
| 2017-12-31 | $3.71 Million | $-22.50 Million | -6.069x | -82.05% |
| 2016-12-31 | $8.26 Million | $-27.54 Million | -3.334x | -- |
About ReWalk Robotics Ltd
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal… Read more